[Home ] [Archive]    
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
Journal Information::
Articles archive::
For Authors::
For Reviewers::
Registration::
Contact us::
Site Facilities::
::
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
:: Volume 15, Issue 1 (6-2017) ::
3 2017, 15(1): 1-7 Back to browse issues page
Indomethacin hybrids as novel cytotoxic compounds
FARZANEH YAZDI , MARYAM ABBASI , HOJJAT SADEGHI-ALIABADI *
Faculty of Pharmacy, Department of Medicinal Chemistry, Isfahan University of Medical Sciences, Isfahan, Iran
Abstract:   (1455 Views)
Cancer is still one of the most invasive health problems around the world although many researches have been done in this field. Different kinds of drugs are developed and used to improve cancer therapy. Some evidence has shown that nonsteroidal anti-inflammatory drugs (NSAIDs) have anticancer activity in addition to anti-inflammatory effects. To improve the safety profile of NSAIDs and enhance anticancer potency, different strategies such as hybridization are used in several studies. Indomethacin is a lead compound in NSAIDs classes' demonstrated inhibitory activity for some malignancies including breast and ovarian cancer. Two kinds of hybrids were proposed and synthesized using diamine linkers via amid bonds: indomethacin-indomethacin (hybrid A) and indomethacin-methotrexate (MTX; hybrid B). To confirm the structures of newly synthesized hybrids, melting points, IR, H NMR were applied. The cytotoxic effects of synthesized hybrids against Hela and MCF-7 cancer cells were evaluated by MTT assay. The results showed that both hybrids were more cytotoxic than indomethacin and MTX alone.
Keywords: NSAIDs, Indomethacin, Hybrid, MTT, Methotrexate
Full-Text [PDF 631 kb]   (826 Downloads)    
Article Type: Research Article | Subject: Other
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA


XML     Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

YAZDI F, ABBASI M, SADEGHI-ALIABADI H. Indomethacin hybrids as novel cytotoxic compounds. 3 2017; 15 (1) :1-7
URL: http://ijpt.iums.ac.ir/article-1-323-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 15, Issue 1 (6-2017) Back to browse issues page
مجله داروشناسی و درمان شناسی ایران Iranian Journal of Pharmacology and Therapeutics
Persian site map - English site map - Created in 0.06 seconds with 39 queries by YEKTAWEB 4642